I.V.F. Does Not Raise Breast Cancer Risk, Study Shows: For years, researches have been struggling to definitively answer whether women undergoing in vitro fertilization are at an increased risk for breast cancer. Studies over the past decade have given varying results, but on Tuesday the most comprehensive study to date found no link, at least for the first few decades after I.V.F. Doctors caution that there’s still a chance cancer may develop later in life, when these women are postmenopausal, but for now it’s a hopeful answer to a long standing question. (The New York Times)
Digital Health Funding 2016 Midyear Review: Many expected 2016 to be the year that venture funding for digital health declined. But halfway through the year, the numbers are telling a very different story. So far the pace of venture funding in 2016 matches the paces sent in 2014 and 2015, both record-breaking funding years in digital health. Companies being funded in 2016 tend to focus on wearable technology, population health management, and analytics. And while California continues to dominate the digital health field, Massachusetts remains in the second tier of funding with New York and newcomer Texas. (Rock Health)
Someone Got Zika in Utah and No One Knows How: Scientists are starting to understand how Zika, a mosquito borne virus currently in epidemic in the Americas and the Pacific, really works. But the latest US case of Zika is baffling researchers everywhere — how a caretaker in Utah managed to contract the disease from the patient they were caring for. This case raises new questions about how Zika transfers and how people are most likely to catch the virus, but it also tends to be the odd cases that lead scientists to the most groundbreaking discoveries about epidemics (Wired).
How Salmonella Could Be Used to Cure Cancer: Jeff Hasty of the University of California, San Diego, has managed to kill tumors in mice using salmonella bacteria. While salmonella is most known for causing food poisoning, Hasty has engineered a strand that destroys itself when it gets to a certain density. That destruction is what kills the tumors. While it’s a long way from human testing, Hasty’s research opens a new door into how we might treat numerous diseases by creating probiotic bombs that self destruct, destroy the disease, and then reseed to continue the process, preventing relapse. (The Atlantic)
Researchers Have Just Doubled What We Know About the Human Brain: A team of researched has nearly doubled the number of known distinct areas in the human brain cortex. This new, high-definition view of the brain might make it easier to detect mental illnesses and neurological diseases using biological markers. It’s also likely to help speed along the develop of better, noninvasive types of neurosurgery. This massive breakthrough is just the tip of the iceberg, however, as researchers hope to refine the scan and show us even more about how our brains work. (The Washington Post)
Casey Nugent is an editorial intern for MedTech Boston. She’s currently working on her BFA in Writing, Literature, and Publishing at Emerson College in Boston. Outside of working at MedTech Boston, Casey enjoys drinking coffee, going to the theater, goofing around with friends, and hanging out with dogs.
Send this to a friend